ISSN: 0027-8874

Journal of the National Cancer Institute Q1 Unclaimed

Oxford University Press United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of the National Cancer Institute is a journal indexed in SJR in Oncology and Cancer Research with an H index of 356. Journal with a Single blind Peer Review review system, and It has a price of 3578 €. The scope of the journal is focused on Cancer, Medicine. It has an SJR impact factor of 5,797 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,797.

Journal of the National Cancer Institute focuses its scope in these topics and keywords: cancer, breast, prostate, clinical, bite, lung, controlled, receptor, risk, group, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

3578 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

5,797

SJR Impact factor

356

H Index

181

Total Docs (Last Year)

680

Total Docs (3 years)

5236

Total Refs

5228

Total Cites (3 years)

459

Citable Docs (3 years)

7,92

Cites/Doc (2 years)

28,93

Ref/Doc

Other journals with similar parameters

JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1

Compare this journals

Aims and Scope

Best articles by citations

For Telomeres, Longer Is Not Always Better

Relationship of Leukemia Risk to Radiation Dose Following Cancer of the Uterine Corpus

Helicobacter pylori Seroprevalence and Colorectal Neoplasia: Evidence Against an Association

Chromosomal Abnormalities in Patients With Hodgkin's Disease: Evidence for Frequent Involvement of the 14q Chromosomal Region but Infrequent bcl-2 Gene Rearrangement in Reed-Sternberg Cells

Risk of Transfusion-Associated Transmission of Human Herpesvirus 8

In Different Cultures, Cancer Screening Presents Challenges

Evaluation of Bias in Familial Risk Estimates: A Study of Common Cancers Using Swedish Population-based Registers

Gender- and Smoking-Related Bladder Cancer Risk

Prostate Cancer Screening at National Cancer Institute Comprehensive and Clinical Cancer Centers

Psychosocial Care Integral for Breast Cancer Patients, Report Concludes

Protein N-Myristoylation as a Chemotherapeutic Target for Cancer

For Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastoma Survivors

SHOW MORE ARTICLES

Common Threads of Mucosa-Associated Lymphoid Tissue Lymphoma Pathogenesis: From Infection to Translocation

Brief Communication: B-Cell Origin of Hamster Lymphoid Tumors Induced by Simian Virus 40

Burkitt's Lymphoma in the Mengo Districts of Uganda: Epidemiologic Features and Their Relationship to Malaria

Suppression of Metastasis--A New Function for Known Proteins

Norwegian Law Brings Alternative Medicine to the Mainstream

As Targeted Therapies Evolve, Challenges Remain

Xenografts Raise Questions About Cancer Virus Transfer to Humans

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations

Male Breast Cancer During Finasteride Therapy

Press Release: Active Smoking Associated With Increased Risk of Breast Cancer

Funding Cuts for Public Health Projects in Europe May Affect International Cancer Effort

Press Release: Aspirin Use May Be Associated With Increased Risk of Pancreatic Cancer

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .